Skip to main navigation
Skip to search
Skip to main content
Ariel University Home
Help & FAQ
Link opens in a new tab
English
עברית
العربية
Search content at Ariel University
Home
Profiles
Research units
Equipment
Research output
Prizes
Activities
Press/Media
Perinatal outcome following third trimester exposure to paroxetine
Adriana Moldovan Costei
, Eran Kozer
, Tommy Ho
, Shinya Ito
, Gideon Koren
Research output
:
Contribution to journal
›
Article
›
peer-review
251
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Perinatal outcome following third trimester exposure to paroxetine'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Third Trimester
100%
Perinatal Outcome
100%
Paroxetine
100%
Neonate
25%
Drug Use
25%
Pregnant Women
25%
Discontinuation Syndrome
25%
First Trimester
12%
Motherisk
12%
Toronto
12%
Opioids
12%
Hypoglycemia
12%
Odds Ratio
12%
Logistic Regression
12%
Clinically Significant
12%
Teratogenic Risk
12%
Jaundice
12%
Prolonged Hospitalization
12%
Second Trimester
12%
Panic Disorder
12%
Late Gestation
12%
Obsessive-compulsive Disorder
12%
Clinical picture
12%
Neonatal Distress
12%
Benzodiazepines
12%
Paroxetine Hydrochloride
12%
Neonatal Complications
12%
Human Placenta
12%
Maternal Depression
12%
Maternal Age
12%
Respiratory Distress
12%
95% Confidence Interval
12%
Intensive Treatment
12%
Neonatal Abstinence Syndrome
12%
Nursing and Health Professions
Paroxetine
100%
Neonate
22%
Drug Use
22%
Withdrawal Syndrome
22%
Logistic Regression Analysis
11%
Odds Ratio
11%
Cohort Analysis
11%
Confidence Interval
11%
Postnatal Depression
11%
Respiratory Distress
11%
Obsessive Compulsive Disorder
11%
Hypoglycemia
11%
Jaundice
11%
Benzodiazepine Derivative
11%
Maternal Age
11%
Neonatal Withdrawal
11%
Opioid
11%
Pharmacology, Toxicology and Pharmaceutical Science
Paroxetine
100%
Withdrawal Syndrome
22%
Cohort Study
11%
Hypoglycemia
11%
Respiratory Distress
11%
Postnatal Depression
11%
Obsessive Compulsive Disorder
11%
Jaundice
11%